본문으로 이동
치킨스탁치킨스탁
종목 탐색투자자

지분 5% 초과 신고

미국 발행사 지분을 5% 넘게 보유하게 되어 낸 신고예요. 보유 목적을 비롯한 항목을 자세히 적는 서식이고, 목적은 신고서에 적힌 원문 그대로만 옮겨요.

지분 5%를 넘긴 뒤 영업일 5일 안에 신고해요. 분기 보유 내역보다 빠르게 공개돼요.

  • ChronoScale Holdings Corp 로고
    CHRNChronoScale Holdings Corp

    Applied Digital Corporation

    정정2026년 11월 20일 신고·사유 발생 2026년 11월 18일
    85.6%
    지분
    신고서에 적힌 목적(원문)

    In connection with the closing of the private placement offering (the "Private Placement") pursuant to the Common Stock Purchase Agreement entered into on November 18, 2026, by and among the Issuer and the purchasers named therein (the "Purchase Agreement"), the Issuer issued an unsecured convertible promissory note (the "Convertible Note") payable to the Reporting Person, providing for an unsecured loan in the aggregate principal amount of $97.0 million (the "Principal Amount"), the entire amount of which has been funded. Upon the effectiveness of the Stockholder Approval (as defined below), the outstanding Principal Amount will automatically convert into 12,125,000 shares of Common Stock, equal to the Principal Amount divided by $8.00 per share, subject to adjustment for stock splits, combinations and reclassifications. No interest accrues or is payable on the Principal Amount, including during the existence of any event of default. The Issuer may not prepay the Convertible Note, in whole or in part, prior to the Maturity Date (as defined below) without the prior written consent of the Reporting Person. The Convertible Note may not be converted into shares of Common Stock prior to the effectiveness of the stockholder approval obtained by written consent in lieu of a meeting, for purposes of Nasdaq Listing Rule 5635(d), if applicable, solely to the extent that the issuance of Common Stock in the Private Placement would exceed 19.99% of the shares of Common Stock issued and outstanding immediately prior to the execution of the Purchase Agreement (as reduced by any shares issued or issuable in any transaction that may be aggregated with the Private Placement under applicable Nasdaq rules (the "Stockholder Approval")). The consent of the Issuer's stockholders, dated November 18, 2026, will become effective on the 20th calendar day following the mailing by the Issuer to the stockholders of the definitive information statement on Schedule 14C. If not otherwise converted pursuant to its terms as described above into shares of Common Stock, the outstanding Principal Amount will mature on December 31, 2026 (the "Maturity Date"). The Convertible Note includes customary representations, warranties, covenants and events of default.

  • Rocket Companies, Inc. 로고
    RKTRocket Companies, Inc.

    Daniel Gilbert

    정정2026년 11월 20일 신고·사유 발생 2025년 12월 16일
    55.44%
    지분
    신고서에 적힌 목적(원문)

    Item 4 of the Schedule 13D is hereby amended by adding the following: Daniel Gilbert contributed (a) 687,047,556 shares of the Issuer's common stock to the Daniel B. Gilbert Trust u/a/d 12/23/96 on June 16, 2026 (which entity previously held 89,859 shares of the Issuer's common stock) and (b) 450,000,000 shares of the Issuer's common stock to The Daniel B. Gilbert 2025 GRAT on December 16, 2025. Daniel Gilbert is the sole trustee and beneficiary of both trusts. The transfers were in connection with ordinary course estate planning.

  • Q/C TECHNOLOGIES, INC. 로고
    QCLSQ/C TECHNOLOGIES, INC.

    PharmaCyte Biotech, Inc.

    정정2026년 11월 20일 신고·사유 발생 2026년 11월 15일
    49.99%
    지분
    신고서에 적힌 목적(원문)

    Item 4 is hereby amended and supplemented as follows: "Consent and Warrant Exchange Agreement. On November 15, 2026, the Reporting Person entered into a Consent and Warrant Exchange Agreement with the Issuer (the "Consent Agreement"), pursuant to which the Reporting Person agreed to exchange 851,304 Series G Long-Term Warrants (the "Exchange Warrants") for an aggregate of 4,982,272 shares of Common Stock (the "Exchange Shares"). The number of Exchange Shares equals the Black-Scholes value of the Exchange Warrants divided by $0.3101 per share, the closing price of the Common Stock on the last trading day before the Consent Agreement was signed. The Exchange Shares were delivered to the Reporting Person on November 18, 2026. In addition, pursuant to the Consent Agreement, the Reporting Person consented to an amendment to the Certificate of Designations extending the maturity date of the Series H Preferred Shares from March 2, 2027 to September 2, 2027 (the "Series H Maturity Amendment"), for no additional consideration. The foregoing descriptions of the Consent Agreement and the Series H Maturity Amendment are qualified in their entirety by reference to the full text of such documents, which are filed as, or incorporated by reference to the filings identified in, Exhibits 10 and 11 to this Schedule 13D and are incorporated herein by reference. On November 20, 2026, the Reporting Person and the Issuer entered into an Omnibus Amendment Agreement (the "Omnibus Agreement"). The Reporting Person holds at least a majority of the outstanding shares of each of the Series G Preferred Stock and the Series H Preferred Stock and thereby constitutes the Required Holders (as defined in the applicable Certificate of Designations). Pursuant to the Omnibus Agreement, the Reporting Person and the Issuer agreed to amend (i) the Series G Certificate of Designations by filing a Certificate of Amendment (the "Series G Amendment") with the Secretary of State of the State of Delaware, (ii) the Series H Certificate of Designations by filing a Certificate of Amendment (the "Series H Beneficial Amendment") with the Secretary of State of the State of Delaware, and (iii) the Series G Long-Term Warrants held by the Reporting Person to amend the amendment provisions and the beneficial ownership limitation provisions contained therein. Under the amended beneficial ownership limitation provisions (the "Beneficial Ownership Limitation"), the Reporting Person may not convert any Series G Preferred Stock or Series H Preferred Stock, or exercise any Series G Long-Term Warrants, to the extent that after giving effect to the conversion or exercise it, together with its affiliates and any other persons whose beneficial ownership would be aggregated with it for purposes of Section 13(d) of the Exchange Act, would beneficially own more than 49.99% of the outstanding Common Stock. The foregoing descriptions of the Omnibus Agreement, the Series H Beneficial Amendment and the Series G Amendment are qualified in their entirety by reference to the full text of such documents, which are filed as, or incorporated by reference to the filings identified in, Exhibits 12, 13 and 14 to this Schedule 13D and are incorporated herein by reference."

  • Guerrilla RF, Inc. 로고
    GUERGuerrilla RF, Inc.

    NR-PRL Partners, LP

    정정2026년 11월 20일 신고·사유 발생 2026년 11월 18일
    48.2%
    지분
    신고서에 적힌 목적(원문)

    Item 4 is hereby amended and supplemented to add the following at the end thereof: The information in Item 5(c) is incorporated herein by reference.

  • KNOT Offshore Partners LP 로고
    KNOPKNOT Offshore Partners LP

    Knutsen NYK Offshore Tankers AS

    정정2026년 11월 20일 신고·사유 발생 2026년 11월 20일
    44.3%
    지분
    신고서에 적힌 목적(원문)

    The information contained in Item 3 above is incorporated herein by reference. KNOT acquired its Common Units (including any Common Units issuable upon conversion of the Class B Units and Series A Preferred Units) for investment purposes and (in the case of the original acquisition of the Subordinated Units) in order to effect the IPO. Each of the Reporting Persons at any time and from time to time may acquire additional Common Units or dispose of any or all of Common Units that it owns depending upon an ongoing evaluation of the investment in the Common Units, prevailing market conditions, other investment opportunities, other investment considerations and/or other factors. Under the Limited Liability Company Agreement of the General Partner, dated February 20, 2013 (the "General Partner LLC Agreement"), KNOT has the right to designate the individuals that serve on the board of directors of the General Partner. The General Partner, in turn, has the right to appoint three of the seven directors of the Partnership. Through KNOT's right to appoint the board of directors of the General Partner and the General Partner's right to appoint three members of the board of directors of the Partnership (the "Board"), KNOT and, indirectly, the other Reporting Persons, have the ability to influence the management, policies and control of the Partnership with the aim of increasing the value of the Partnership, and thus of the Reporting Persons' investment. The Reporting Persons continuously evaluate their investment in the Issuer and its subsidiaries and, depending on various factors including, but not limited to, the price of the Common Units, the terms and conditions of available transactions, prevailing market conditions and such other considerations as the Reporting Persons deem relevant may, at any time or from time to time, and subject to any required regulatory approvals, acquire or dispose of additional Common Units, Series A Preferred Units and/or other equity, debt, notes, instruments or other securities of the Issuer and/or its subsidiaries on the open market, in privately negotiated transactions, directly from or to the Issuer, upon the exercise or conversion of securities convertible into or exercisable or exchangeable for other securities or otherwise. Any such acquisition, disposition or other transaction could be effectuated through open market purchases, tender or exchange offers, exercise of the limited call right contained in the Partnership Agreement, negotiated merger transactions, privately negotiated transactions, sale transactions or otherwise. The Reporting Persons may, at any time and from time to time, review or reconsider their position and/or change their purpose and/or formulate plans or proposals with respect thereto.

  • DAVION HEALTHCARE PLC 로고
    DAVIDAVION HEALTHCARE PLC

    JACK HARRY KAYE

    정정2026년 11월 20일 신고·사유 발생 2026년 11월 19일
    34.68%
    지분
    신고서에 적힌 목적(원문)

    On November 19, 2026, the Reporting Person transferred an aggregate of 1,600,000 ordinary shares of the Issuer by way of four separate bona fide gifts to four individuals. The transfers were made without consideration and were not undertaken in connection with any sale, financing, or other capital-raising transaction involving the Issuer. The Reporting Person did not retain voting or dispositive power over the gifted shares. Following the gifts, the Reporting Person continued to beneficially own 8,668,948 ordinary shares. The Reporting Person remains Executive Chairman of the Issuer. Except as disclosed herein and in the Schedule 13D as previously amended, the Reporting Person has no additional plans or proposals requiring disclosure under Item 4.

  • Versa Bancorp 로고
    VRSAVersa Bancorp

    GBH Inc.

    2026년 11월 20일 신고·사유 발생 2026년 11월 13일
    29.9%
    지분
    신고서에 적힌 목적(원문)

    The Reporting Persons acquired the shares of Common Stock reported herein in connection with the Reorganization, pursuant to which the Issuer became the holding company of VersaBank and succeeded VersaBank as the publicly traded company in which shareholders of VersaBank held their equity interest. The Reporting Persons hold the Common Stock for investment purposes. Each Reporting Person may, if permitted and depending on market and other conditions, increase or decrease its or his beneficial ownership of securities of the Issuer through open market transactions, private agreements, transfers between the Reporting Persons or otherwise. In connection with any equity offering that the Issuer may undertake, GBH may sell a portion of its shares as part of a secondary component of such offering, subject to market conditions and other relevant considerations. Except as set forth above, neither Reporting Person has any present plans or proposals that relate to or would result in any of the actions described in paragraphs (a) through (j) of Item 4 of Schedule 13D. The Reporting Persons reserve the right to change their plans and intentions at any time.

  • Nexxen International Ltd. 로고
    NEXNNexxen International Ltd.

    Mithaq Capital SPC

    정정2026년 11월 20일 신고·사유 발생 2026년 11월 18일
    26.6%
    지분

    이 신고서에는 목적을 적은 항목이 없어요.

  • Jinxin Technology Holding Co 로고
    NAMIJinxin Technology Holding Co

    Namibox Technology Limited

    2026년 11월 20일 신고·사유 발생 2026년 10월 30일
    26.5%
    지분
    신고서에 적힌 목적(원문)

    The information set forth in Item 3 is hereby incorporated by reference in its entirety. The beneficial ownership that is the subject of this Schedule 13D was acquired for investment purposes. The Reporting Persons review its investments in the Issuer on a continuing basis. Depending on overall market conditions, performance and prospects of the Issuer, subsequent developments affecting the Issuer, other investment opportunities available to the Reporting Persons and other investment considerations, the Reporting Persons may acquire additional securities, make investment arrangements with respect to the securities beneficially owned, or to continue to hold its existing position in the securities, all in compliance with applicable requirements and restrictions. Any of the foregoing actions may be effected at any time or from time to time, subject to applicable law. Except as set forth above, none of the Reporting Persons has any present plan or proposal which related to or would result in any transaction, change or event specified in clauses (a) through (j) of Item 4 of Schedule 13D. The Reporting Persons reserve the right to take such actions in the future as they deem appropriate, including changing the purpose described above or adopting plans or proposals with respect to one or more of the items described in clauses (a) through (j) of Item 4 of Schedule 13D.

  • Powell Max Ltd 로고
    PMAXPowell Max Ltd

    Hyperscale Data, Inc.

    정정2026년 11월 20일 신고·사유 발생 2026년 11월 18일
    20.2%
    지분

    이 신고서에는 목적을 적은 항목이 없어요.

  • Primo Brands Corp 로고
    PRMBPrimo Brands Corp

    ORCP III DE TopCo GP, LLC

    정정2026년 11월 20일 신고·사유 발생 2026년 11월 18일
    19.2%
    지분

    이 신고서에는 목적을 적은 항목이 없어요.

  • GLOBAL PAYMENTS INC. 로고
    GPNGLOBAL PAYMENTS INC.

    GTCR W Aggregator LP

    2026년 11월 20일 신고·사유 발생 2026년 11월 20일
    16.35%
    지분
    신고서에 적힌 목적(원문)

    On January 9, 2026, the Issuer acquired Worldpay Holdco, LLC from Fidelity National Information Services, Inc. and the Reporting Persons (the "Worldpay Acquisition") and, in connection with such transaction, the Reporting Persons acquired the 43,268,041 shares of Common Stock reported herein as partial consideration for their interests in Worldpay Holdco, LLC. The Reporting Persons originally reported their acquisition of the shares of Common Stock on a Schedule 13G. From time to time since the date of such acquisition, the Reporting Persons have engaged in evaluations of the Issuer and its business, including related discussions with management of the Issuer, other shareholders, advisors and other persons. Based on current market conditions and other factors, and subject to the following paragraph, the Reporting Persons are evaluating possible strategic transactions involving the Issuer, which may involve a potential proposal to acquire additional or all outstanding shares of Common Stock not currently held by the Reporting Persons (a "Proposal"), and any such Proposal may involve communications regarding the foregoing with, among others, management of the Issuer, the Board of Directors of the Issuer (the "Board"), other shareholders and stakeholders of the Issuer, potential co-investors, potential acquirers, service providers, debt and equity financing sources and/or other relevant parties. The Reporting Persons continue to evaluate and explore discussions and actions associated with acquiring, holding, voting or disposing of securities of the Issuer, but no definitive determination as to the foregoing has been made. However, based on the status of their evaluation of the Issuer and the Issuer's business to date, as well as current market conditions, the Reporting Persons may determine to submit a Proposal to the Issuer. Any such action may be taken alone or in conjunction, including following discussions, with other shareholders and stakeholders of the Issuer, potential co-investors, potential acquirers, service providers, debt and equity financing sources and/or other relevant parties. Any such action could include one or more purposes, plans or proposals that relate to or would result in actions concerning a potential strategic transaction involving the Issuer and other actions required to be reported herein in accordance with Item 4 of Schedule 13D. No assurances can be given that any Proposal, if submitted, would be accepted or that any transaction contemplated by a Proposal with the Issuer will be consummated. No binding obligation on the part of the Reporting Persons will arise unless and until mutually acceptable definitive documentation has been executed and delivered. The Reporting Persons intend to regularly review their investment in the Issuer on a continuing basis. From time to time and at any time in the future, they may take such actions with respect to their investment in the Issuer as they deem appropriate, depending on various factors. These factors include, without limitation, the outcome of any Proposal referenced in this Schedule 13D, as may be amended from time to time; any limitations imposed by the Issuer's financial position and strategic direction; actions taken by the Board; price levels of the Issuer's securities; other investment opportunities available to the Reporting Persons; conditions in the securities market; and general economic and industry conditions. Subject to compliance with the Shareholders Agreement, including the standstill obligations included therein, these actions may include (i) acquiring additional shares of Common Stock and/or other equity, debt, notes, other securities, or derivative or other instruments that are based upon or relate to the value of securities of the Issuer (collectively, "Securities"), in the open market or otherwise; (ii) disposing of any or all of their Securities in the open market or otherwise; (iii) engaging in any hedging or similar transactions with respect to the Securities; or (iv) proposing or considering one or more of the actions described in subsections (a) through (j) of Item 4 of Schedule 13D. Although the foregoing reflects activities presently contemplated by the Reporting Persons, the foregoing is subject to change at any time, and the Reporting Persons reserve their right to change their plans and intentions with respect to the Issuer, including in connection with any of the actions discussed in this Item 4. Any action taken by the Reporting Persons may be effectuated at any time and from time to time, subject to any applicable limitations imposed by any applicable laws and by the Shareholders Agreement. Neither any Proposal nor this Schedule 13D is meant to be, nor should be construed as an offer to buy or the solicitation of an offer to sell any of the Issuer's securities.

  • NORTHERN DYNASTY MINERALS LTD 로고
    NAKNORTHERN DYNASTY MINERALS LTD

    Northern Dynasty Minerals Ltd

    정정2026년 11월 20일 신고·사유 발생 2026년 11월 18일
    15.3%
    지분
    신고서에 적힌 목적(원문)

    The Reporting Persons purchased the Issuer's securities based on the Reporting Persons' belief that such securities, when purchased, were undervalued and represented an attractive investment opportunity. Depending upon overall market conditions, other investment opportunities available to the Reporting Persons, and the availability of Common Shares at prices that would make the purchase or sale of Common Shares desirable, the Reporting Persons intend to continue to review their investment in the Issuer on an ongoing basis and may, from time to time and at any time, acquire additional Common Shares in the open market or otherwise, dispose of any or all of the Common Shares in the open market or otherwise, and/or engage in hedging or similar transactions with respect to the Common Shares. On March 24, 2023, Ms. Isabel Satra was appointed as a director of the Issuer. Ms. Satra is currently a Principal at Kopernik Global Investors and serves as the firm's Chief Financial Officer. As a result of Ms. Satra's appointment to the Board, the Reporting Persons previously converted the beneficial ownership filing on Schedule 13G to a filing on Schedule 13D. The Reporting Persons have engaged, and intend to continue to engage, in discussions and other communications with management and the Board of Directors (the "Board") of the Issuer, regarding a variety of matters relating to the Issuer, which may include, among other things, the composition of the Board and corporate governance. No Reporting Person has any present plan or proposal which would relate to or result in any of the matters set forth in subparagraphs (a) - (j) of Item 4 of Schedule 13D except as set forth herein or such as would occur upon or in connection with completion of, or following, any of the actions discussed herein. The Reporting Persons intend to review their investment in the Issuer on a continuing basis. Depending on various factors including, without limitation, the Issuer's financial position and investment strategy, the price levels of the Common Shares, conditions in the securities markets and general economic and industry conditions, the Reporting Persons may in the future take such actions with respect to their investment in the Issuer as they deem appropriate including, without limitation, engaging in additional communications with management and the Board, engaging in discussions with stockholders of the Issuer or other third parties about the Issuer and the Reporting Persons' investment, including potential business combinations or dispositions involving the Issuer or certain of its businesses, making recommendations or proposals to the Issuer concerning changes to the capitalization, ownership structure, board structure (including board composition), potential business combinations or dispositions involving the Issuer or certain of its businesses, or suggestions for improving the Issuer's financial and/or operational performance, purchasing additional Common Shares, selling some or all of their Common Shares, engaging in short selling of or any hedging or similar transaction with respect to the Common Shares, including swaps and other derivative instruments, or changing their intention with respect to any and all matters referred to in Item 4.

  • NIP Group Inc. 로고
    NIPGNIP Group Inc.

    Noveau Jumpstar Limited

    2026년 11월 20일 신고·사유 발생 2026년 11월 13일
    15.2%
    지분
    신고서에 적힌 목적(원문)

    On May 29, 2026, the Issuer, Noveau and certain other parties (together, the "Sellers") entered into a second amendment to the Tranche 2 APA (the "Tranche 2 APA Amendment"), pursuant to which the Issuer agreed to acquire from the Sellers on-rack crypto mining machines, in consideration of the issuance by the Issuer of certain Class A Ordinary Shares. Noveau received the consideration shares of 18,787,896 Class A Ordinary Shares of the Issuer on May 29, 2026. On September 24, 2026, the Issuer, Noveau and certain other parties entered into an on-rack sales and purchase agreement (the "Agreement"), pursuant to which the Issuer agreed to acquire from the Sellers on-rack crypto mining machines with an aggregate hashrate of 4,468,708 terahashes per second, in consideration of the issuance by the Issuer of up to 247,091,499 Class A Ordinary Shares (the "Transaction"). On November 4, 2026, the Issuer, Noveau and certain other parties entered into an amendment to the Agreement (the "Amendment"), pursuant to which, among other things, the Amendment had updated the closing schedule of the Transaction, including the amount of the consideration shares to be issued by the Issuer for each closing. Noveau received the consideration shares of 79,504,980 Class A Ordinary Shares of the Issuer on November 13, 2026 in connection with the initial closing of the Transaction. As of November 13, 2026, 98,292,876 Class A Ordinary Shares had been issued to and registered in the name of Noveau. Pursuant to the Agreement as amended by the Amendment, additional consideration shares may be issued to Noveau at the other closings. On October 16, 2026, Noveau, the Issuer and certain other parties entered into the Second Amended and Restated Investor Rights Agreement (the "Investor Rights Agreement"), according to which Noveau is entitled to customary registration rights and the right to appoint one director of the Issuer. As of November 20, 2026, Noveau had appointed Ms. JIANG Olga Sheng to the board of the Issuer. The information set forth in Item 6 of this Schedule 13D is hereby incorporated by reference in its entirety. Other than as set forth in this Schedule 13D, no Reporting Person has any present plans or proposals which relate to or would result in: (a) The acquisition by any person of additional securities of the Issuer, or the disposition of securities of the Issuer; (b) An extraordinary corporate transaction, such as a merger, reorganization or liquidation, involving the Issuer or any of its subsidiaries; (c) A sale or transfer of a material amount of assets of the Issuer or of any of its subsidiaries; (d) Any change in the present board of directors or management of the Issuer, including any plans or proposals to change the number or term of directors or to fill any existing vacancies on the board; (e) Any material change in the present capitalization or dividend policy of the Issuer; (f) Any other material change in the Issuer's business or corporate structure; (g) Changes in the Issuer's charter, bylaws or instruments corresponding thereto or other actions which may impede the acquisition of control of the Issuer by any person; (h) A class of securities of the Issuer being delisted from a national securities exchange or ceasing to be authorized to be quoted in an inter-dealer quotation system of a registered national securities association; (i) A class of equity securities of the Issuer becoming eligible for termination of registration pursuant to Section 12(g)(4) of the Act; or (j) Any action similar to any of those enumerated above.

  • Merlin, Inc. 로고
    MRLNMerlin, Inc.

    George Matthew Spencer

    정정2026년 11월 20일 신고·사유 발생 2026년 11월 18일
    14.5%
    지분
    신고서에 적힌 목적(원문)

    This Amendment No. 1 (this "Amendment") amends and supplements the Schedule 13D filed with the Securities and Exchange Commission on March 23, 2026 (the "Original Schedule 13D" and, as amended and supplemented by this Amendment, this "Schedule 13D") by Matthew George (the "Reporting Person") relating to the common stock, par value $0.0001 per share (the "Common Stock"), of Merlin, Inc. (the "Issuer"). Except as specifically amended and supplemented by this Amendment, the Original Schedule 13D remains in full force and effect. Capitalized terms used but not defined herein have the meanings given to them in the Original Schedule 13D. Item 4 of the Original Schedule 13D is hereby amended and supplemented by adding the following: Transition Agreement On November 18, 2026, the Reporting Person and the Issuer entered into a Transition Agreement (the "Transition Agreement"), pursuant to which, effective as of November 18, 2026 (the "Transition Date"), the Reporting Person ceased to serve as the Chief Executive Officer of the Issuer and Chairman of the Issuer's Board of Directors (the "Board") and resigned from all of his positions with the Issuer and its affiliates, including all director, officer, employee and fiduciary positions, except for his position as Founder and Advisor. On November 19, 2026, the Issuer announced the transition and the appointment of Dr. Robert H. Smith as Interim Chief Executive Officer and Chairman of the Board, and filed a Current Report on Form 8-K with respect thereto. Under the Transition Agreement, the Reporting Person will serve as Founder and Advisor, as an independent consultant reporting to the Board, from and including the Transition Date until the first anniversary of the Transition Date, unless earlier terminated (such period, the "Advisory Period"), for a monthly services fee of $6,250, and will provide transition assistance and advice as reasonably requested by the Board, not to exceed 15 hours per month. The Transition Agreement provides for separation payments and benefits in satisfaction of the Issuer's Executive Severance Plan, including a cash payment of $937,500 payable in substantially equal installments over the 18 months following the Transition Date, a cash payment of $625,000 in respect of the Reporting Person's 2026 target annual bonus, and an 18-month subsidy towards the cost of continued medical insurance benefits under the Issuer's group health plan in accordance with the Consolidated Omnibus Budget Reconciliation Act of 1986, as amended (the "COBRA Subsidy"), as well as certain additional payments equal to $937,500 and six times the monthly COBRA Subsidy, in the event a change in control of the Issuer occurs within specified periods following the Transition Date, in each case subject to the Reporting Person's execution and non-revocation of a general release of claims. Treatment of Equity Awards Pursuant to the Transition Agreement, the Reporting Person's outstanding stock options and restricted stock units did not vest in connection with his termination of employment and instead continue to vest during the Advisory Period pursuant to the terms of the applicable award agreements and equity incentive plans. Upon a termination of the Reporting Person's service as Founder and Advisor for any reason other than by the Issuer for cause or by the Reporting Person prior to the first anniversary of the Transition Date (other than as a result of the Issuer's material breach), the then-remaining unvested portion of each option and restricted stock unit award will vest; if such service is terminated by the Reporting Person prior to the first anniversary of the Transition Date (other than as a result of the Issuer's material breach), the portion of each award that would have vested had his service continued through the first anniversary will vest. In addition, if a change in control of the Issuer occurs on or prior to the first anniversary of the Transition Date while the Reporting Person is continuing to provide services as Founder and Advisor, all unvested options and restricted stock units then outstanding will vest. Vested options remain outstanding and exercisable until their initial expiration dates. Standstill Under the Transition Agreement, for a period of three years following the Transition Date (the "Standstill Period"), the Reporting Person has agreed, subject to specified exceptions, not to, among other things: acquire or seek to acquire any securities of the Issuer (other than upon the exercise or vesting of equity awards or pursuant to stock splits, stock dividends or similar corporate transactions initiated by the Issuer); propose or seek to effect any tender or exchange offer, merger, business combination, recapitalization, restructuring or other extraordinary transaction involving the Issuer; make or participate in any solicitation of proxies, or seek to advise or influence any person with respect to the voting of any voting securities of the Issuer (other than in favor of proposals supported by the Board); form or participate in any "group" within the meaning of Section 13(d) of the Securities Exchange Act of 1934 with respect to any voting securities of the Issuer; act to seek to control, change or influence the management, Board or policies of the Issuer; commence or support any derivative action in the name of the Issuer or any class action against the Issuer; engage in any short sale or similar transaction with respect to securities of the Issuer; or publicly disclose any intention, plan or arrangement inconsistent with the foregoing. The standstill does not prevent the Reporting Person from selling any voting securities owned by him, provided such sales are permissible under applicable federal and state securities laws, and the Issuer has confirmed that no contractual restrictions between the Issuer and the Reporting Person apply to any such sale. While the Reporting Person is an affiliate of the Issuer, the Issuer has agreed not to unreasonably withhold or delay its approval of any sale of the Issuer's shares by the Reporting Person that complies with securities laws and to reasonably cooperate with any such sale. Voting Proxy Under the Transition Agreement, the Reporting Person has agreed to vote, or cause to be voted, at any meeting of stockholders held during the Standstill Period, all shares of the Issuer's stock held directly or indirectly by him, whether now owned or hereafter acquired, over which he has voting control, in accordance with the disinterested stockholders of the Issuer on any proposal, and has granted the Issuer an irrevocable proxy to so vote such shares during the Standstill Period. The standstill and voting provisions described above terminate upon a material breach of the Transition Agreement by the Issuer that is not cured within 15 days after written notice from the Reporting Person. The Transition Agreement also contains non-competition, non-solicitation, non-interference, non-disparagement, confidentiality, cooperation and intellectual property provisions, and provisions regarding indemnification of the Reporting Person by the Issuer and continuation of directors' and officers' liability insurance coverage. The foregoing description of the Transition Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the Transition Agreement, which is filed as Exhibit 99.3 to this Schedule 13D and incorporated herein by reference. General The Reporting Person intends to review his investments in the Issuer on a continuing basis. Subject to the terms of the Transition Agreement (including the standstill and voting provisions described above) and applicable securities laws, the Reporting Person may retain or sell all or a portion of the securities he holds in the open market or in privately negotiated transactions. Except as set forth in this Schedule 13D (including the arrangements under the Transition Agreement described herein), the Reporting Person does not currently have any plans or proposals that relate to, or would result in, any of the matters listed in Items 4(a)-(j) of Schedule 13D; the standstill provisions of the Transition Agreement restrict the Reporting Person from pursuing many such matters during the Standstill Period.

  • ENOVIX CORPORATION 로고
    ENVXWENOVIX CORPORATION

    Thurman J. Rodgers

    정정2026년 11월 20일 신고·사유 발생 2026년 11월 18일
    12.7%
    지분
    신고서에 적힌 목적(원문)

    Reflects the aggregate number of Dividend Warrants distributed on November 18, 2026 to the Issuer's record holders of Common Stock and Convertible Notes as of November 13, 2026.

  • Medifast, Inc. 로고
    MEDMedifast, Inc.

    Steamboat Capital Partners, LLC

    정정2026년 11월 20일 신고·사유 발생 2026년 11월 19일
    8.6%
    지분

    이 신고서에는 목적을 적은 항목이 없어요.

  • SRX Global Inc. 로고
    SRXHSRX Global Inc.

    Egan Kevin

    2026년 11월 20일 신고·사유 발생 2026년 11월 19일
    7.9%
    지분
    신고서에 적힌 목적(원문)

    The Reporting Persons purchased the Shares based on the Reporting Persons' belief that the Shares, when purchased, were undervalued and represented an attractive investment opportunity. Depending upon overall market conditions, other investment opportunities available to the Reporting Persons, and the availability of Shares at prices that would make the purchase or sale of Shares desirable, the Reporting Persons may endeavor to increase or decrease their position in the Issuer through, among other things, the purchase or sale of Shares on the open market or in private transactions or otherwise, on such terms and at such times as the Reporting Persons may deem advisable. The Reporting Persons intend to engage constructively with the Issuer's Board of Directors (the "Board") and management team regarding opportunities to enhance stockholder value, including, among other matters, through potential changes to the composition of the Board. No Reporting Person has any present plan or proposal which would relate to or result in any of the matters set forth in subparagraphs (a) - (j) of Item 4 of Schedule 13D except as set forth herein or such as would occur upon or in connection with completion of, or following, any of the actions discussed herein. Depending on various factors including, without limitation, the Issuer's financial position and investment strategy, the price levels of the Shares, conditions in the securities markets and general economic and industry conditions, the Reporting Persons may in the future take such actions with respect to their investment in the Issuer as they deem appropriate including, without limitation, engaging in additional communications with management and the Board of the Issuer, engaging in discussions with stockholders of the Issuer or third parties, including potential acquirers and service providers about the Issuer and the Reporting Persons' investment, making proposals to the Issuer concerning changes to the capital allocation strategy, capitalization, ownership structure, including a sale of the Issuer as a whole or in parts, Board structure (including Board composition) or operations of the Issuer, purchasing additional Shares, selling some or all of their Shares, engaging in short selling of or any hedging or similar transaction with respect to the Shares, or changing their intention with respect to any and all matters referred to in Item 4.

  • SKYX Platforms Corp. 로고
    SKYXSKYX Platforms Corp.

    Rani R. Kohen

    정정2026년 11월 20일 신고·사유 발생 2026년 11월 12일
    7.7%
    지분

    이 신고서에는 목적을 적은 항목이 없어요.

  • Destiny Tech100 Inc. 로고
    DXYZDestiny Tech100 Inc.

    Saba Capital Management, L.P.

    2026년 11월 20일 신고·사유 발생 2026년 11월 18일
    7.58%
    지분
    신고서에 적힌 목적(원문)

    The Reporting Persons acquired the Common Shares to which this Schedule 13D relates in the ordinary course of business for investment purposes because they believe that the Common Shares are undervalued and represent an attractive investment opportunity. The Reporting Persons may engage in discussions with management, the Board of Directors (the "Board"), other shareholders of the Issuer and other relevant parties, including representatives of any of the foregoing, concerning the Reporting Persons' investment in the Common Shares and the Issuer, including, without limitation, matters concerning the Issuer's business, operations, board appointments, governance, performance, management, capitalization, trading of the Common Shares at a discount to the Issuer's net asset value and strategic plans and matters relating to the open or closed end nature of the Issuer and timing of any potential liquidation of the Issuer. The Reporting Persons may exchange information with any persons pursuant to appropriate confidentiality or similar agreements or otherwise, work together with any persons pursuant to joint agreements or otherwise, propose changes in the Issuer's business, operations, board appointments, governance, management, capitalization, strategic plans or matters relating to the open or closed end nature of the Issuer or timing of any potential liquidation of the Issuer, or propose or engage in one or more other actions set forth herein. The Reporting Persons may also propose or take one or more of the actions described in subsections (a) through (j) of Item 4 of Schedule 13D, including the solicitation of proxies, and may discuss such actions with the Issuer and Issuer's management and the Board, other stockholders of the Issuer and other interested parties. The Reporting Persons may make binding or non-binding shareholder proposals, or may nominate one or more individuals as nominees for election to the Board in connection with their investment in the Common Shares of the Issuer. The Reporting Persons intend to review their investment in the Issuer on a continuing basis. Depending on various factors, including, without limitation, the outcome of any discussions referenced above, the Issuer's financial position and strategic direction, actions taken by management or the Board, price levels of the Common Shares, other investment opportunities available to the Reporting Persons, conditions in the securities market and general economic and industry conditions, the Reporting Persons may in the future take such actions with respect to their investment in the Issuer as they deem appropriate, including, without limitation, purchasing additional Common Shares or selling some or all of their Common Shares, establishing, maintaining, increasing or decreasing any short position or hedging or similar position they may have now or in the future with respect to the Common Shares, and/or otherwise changing their intention with respect to any and all matters referred to in Item 4 of Schedule 13D. Furthermore, the Reporting Person may seek to influence the Issuer to engage in share buy-backs, tenders, and liquidations and/or to change its governance, investment strategy and/or investment manager (which may be the Reporting Person). The Reporting Persons may, at any time and from time to time, review or reconsider their position and/or change their purpose and/or formulate plans or additional proposals with respect to their investment in the Common Shares. The Reporting Persons have not entered into any agreement with any third party to act together for the purpose of acquiring, holding, voting or disposing of the Common Shares reported herein.

  • SVRN, Inc. 로고
    SVRNSVRN, Inc.

    Proximity Labs

    2026년 11월 20일 신고·사유 발생 2025년 10월 28일
    6.3%
    지분
    신고서에 적힌 목적(원문)

    The Reporting Persons acquired the securities reported in this Schedule 13D in connection with the private placement transactions entered into by the Issuer on October 27, 2025 and closed on October 28, 2025 (collectively, the "PIPE Transaction"), in which the Issuer issued shares of Common Stock and pre-funded warrants to purchase Common Stock to investors for cash and NEAR Tokens. The Issuer disclosed that it intended to use the proceeds of the PIPE Transaction principally to acquire NEAR Tokens and establish NEAR treasury operations. The Reporting Persons acquired the Common Stock as an investment in the Issuer in connection with its adoption of a NEAR-centric digital asset treasury strategy. Concurrently with the PIPE Transaction, Proximity Labs acquired 241,362 of the 500,000 then-outstanding shares of Series B Preferred Stock from Diana Shipping. Each share of Series B Preferred Stock entitles its holder to 2,000 votes on all matters submitted to a vote of the Issuer's stockholders, voting together with the Common Stock as a single class, subject to the voting limitations described in Item 5. Because the Series B Preferred Stock carries enhanced voting rights, the Reporting Persons may be deemed to have acquired and to hold securities of the Issuer with the purpose or effect of influencing control of the Issuer. Accordingly, the Reporting Persons do not hold their securities of the Issuer solely for passive investment purposes and are reporting their beneficial ownership on Schedule 13D. As disclosed by the Issuer in its Report on Form 6-K furnished to the Securities and Exchange Commission (the "SEC") on October 28, 2025, in connection with the PIPE Transaction: (i) the Issuer's board of directors amended the Statement of Designation governing the Series B Preferred Stock to limit the voting power that any individual holder, together with its affiliates and related parties, may exercise by virtue of the Series B Preferred Stock to 9.99% of the total voting power of the Issuer's outstanding voting securities; (ii) the holders of the Issuer's Series B Preferred Stock and Series E Preferred Stock agreed to sell all of such shares to certain purchasers in the PIPE Transaction and incoming members of management; (iii) the Issuer amended and restated its stockholders rights agreement; and (iv) effective October 28, 2025, Semiramis Paliou resigned as Chairperson and a member of the Issuer's board of directors, and Salvatore Ternullo was appointed to fill the resulting vacancy as a Class I Director, Chairperson and Co-Chief Executive Officer of the Issuer. The Issuer subsequently disclosed that, effective October 7, 2026, Mr. Ternullo became the Issuer's sole Chief Executive Officer and continues to serve as Chairman of its board of directors. None of the Reporting Persons nominated, designated or proposed Mr. Ternullo for appointment to any position with the Issuer, and none of the Reporting Persons has any agreement or understanding with Mr. Ternullo with respect to the Issuer or its securities. Proximity Labs agreed, pursuant to a lock-up letter agreement with the Issuer dated October 27, 2025 (the "Lock-Up Agreement"), not to sell, transfer, pledge, hedge or otherwise dispose of its Common Stock and certain related securities, subject to customary exceptions, until the effectiveness of the resale registration statement required by the Subscription Agreement and, with respect to 50% of such securities, for an additional 30 days thereafter, subject to automatic termination 180 days after the closing date of the PIPE Transaction or when such securities could be sold without restriction under Rule 144. As of the date of this Schedule 13D, the restrictions under the Lock-Up Agreement have terminated in accordance with their terms. The Issuer filed a registration statement on Form F-3 with the SEC on November 26, 2025, registering, among other securities, the resale of the shares of Common Stock held by Proximity Labs. The Reporting Persons intend to review their investment in the Issuer on a continuing basis. Depending on various factors, including the Issuer's financial position and strategic direction, the price of the Common Stock and of NEAR Tokens, conditions in the securities and digital asset markets, and general economic and industry conditions, the Reporting Persons may in the future take such actions with respect to their investment in the Issuer as they deem appropriate. Such actions may include purchasing additional securities of the Issuer, selling some or all of their securities of the Issuer (including pursuant to the Issuer's resale registration statement or Rule 144), voting their shares of Common Stock and Series B Preferred Stock on matters submitted to the Issuer's stockholders, and engaging in communications with the Issuer's management, board of directors and other stockholders regarding the Issuer's business, strategy and governance. Except as set forth in this Schedule 13D, none of the Reporting Persons has any present plans or proposals that relate to or would result in any of the actions specified in clauses (a) through (j) of Item 4 of Schedule 13D. The Reporting Persons reserve the right to formulate other plans or proposals, and to take any action with respect to their investment in the Issuer, including any or all of the actions set forth in this Item 4, at any time and from time to time.

  • CSB Financial Inc. 로고
    CSBACSB Financial Inc.

    SEIDMAN & ASSOCIATES LLC ET AL

    2026년 11월 20일 신고·사유 발생 2026년 11월 19일
    5.44%
    지분
    신고서에 적힌 목적(원문)

    The Reporting Persons originally purchased the Shares based on the Reporting Persons' belief that the Shares, when purchased, were undervalued and represented an attractive investment opportunity. Depending upon overall market conditions, other investment opportunities available to the Reporting Persons, and the availability of Shares at prices that would make the purchase or sale of Shares desirable, the Reporting Persons may endeavor to increase or decrease their position in the Issuer through, among other things, the purchase or sale of Shares on the open market or in private transactions or otherwise, on such terms and at such times as the Reporting Persons may deem advisable. None of the Reporting Persons or, to the best of the Reporting Persons' knowledge, the persons listed on Exhibit 1 has any present plan or proposal which would relate to or result in any of the matters set forth in subparagraphs (a) - (j) of Item 4 of Schedule 13D, except as set forth herein or such as would occur upon completion of any of the actions discussed herein. The Reporting Persons intend to review their investment in the Issuer on a continuing basis. Depending on various factors, including, without limitation, the Issuer's financial position and results of operations, the Reporting Persons' investment strategy, the price levels of the Shares, conditions in the securities markets and general economic and industry conditions, the Reporting Persons may in the future take such actions with respect to their investment in the Issuer as they deem appropriate, including, without limitation, engaging in further communications with management and the Board of the Issuer, engaging in discussions with third parties about the Issuer and the Reporting Persons' investment, making proposals to the Issuer concerning changes to the capitalization, ownership structure or operations of the Issuer, purchasing additional Shares, selling some or all of their Shares, engaging in short selling of or any hedging or similar transaction with respect to the Shares, or changing their intention with respect to any and all matters referred to in Item 4.

  • HYSTER-YALE, INC. 로고
    HYHYSTER-YALE, INC.

    GAMCO INVESTORS, INC. ET AL

    정정2026년 11월 20일 신고·사유 발생 2026년 11월 19일
    5.1%
    지분
    신고서에 적힌 목적(원문)

    The Reporting Persons file the long form Schedule 13D pursuant to Section 13d-1 of the Securities Exchange Act of 1934 (the "Act") even though they may be technically eligible to file the short form Schedule G. Because the Reporting Persons may regularly communicate with the Issuer's management, filing the Schedule 13D ensures that these conversations are compliant with the reporting obligations under the Exchange Act.

  • Virtus Total Return Fund Inc. 로고
    ZTRVirtus Total Return Fund Inc.

    Saba Capital Management, L.P.

    2026년 11월 20일 신고·사유 발생 2026년 11월 18일
    5.09%
    지분
    신고서에 적힌 목적(원문)

    The Reporting Persons acquired the Common Shares to which this Schedule 13D relates in the ordinary course of business for investment purposes because they believe that the Common Shares are undervalued and represent an attractive investment opportunity. The Reporting Persons may engage in discussions with management, the Board of Directors (the "Board"), other shareholders of the Issuer and other relevant parties, including representatives of any of the foregoing, concerning the Reporting Persons' investment in the Common Shares and the Issuer, including, without limitation, matters concerning the Issuer's business, operations, board appointments, governance, performance, management, capitalization, trading of the Common Shares at a discount to the Issuer's net asset value and strategic plans and matters relating to the open or closed end nature of the Issuer and timing of any potential liquidation of the Issuer. The Reporting Persons may exchange information with any persons pursuant to appropriate confidentiality or similar agreements or otherwise, work together with any persons pursuant to joint agreements or otherwise, propose changes in the Issuer's business, operations, board appointments, governance, management, capitalization, strategic plans or matters relating to the open or closed end nature of the Issuer or timing of any potential liquidation of the Issuer, or propose or engage in one or more other actions set forth herein. The Reporting Persons may also propose or take one or more of the actions described in subsections (a) through (j) of Item 4 of Schedule 13D, including the solicitation of proxies, and may discuss such actions with the Issuer and Issuer's management and the Board, other stockholders of the Issuer and other interested parties. The Reporting Persons may make binding or non-binding shareholder proposals, or may nominate one or more individuals as nominees for election to the Board in connection with their investment in the Common Shares of the Issuer. The Reporting Persons intend to review their investment in the Issuer on a continuing basis. Depending on various factors, including, without limitation, the outcome of any discussions referenced above, the Issuer's financial position and strategic direction, actions taken by management or the Board, price levels of the Common Shares, other investment opportunities available to the Reporting Persons, conditions in the securities market and general economic and industry conditions, the Reporting Persons may in the future take such actions with respect to their investment in the Issuer as they deem appropriate, including, without limitation, purchasing additional Common Shares or selling some or all of their Common Shares, establishing, maintaining, increasing or decreasing any short position or hedging or similar position they may have now or in the future with respect to the Common Shares, and/or otherwise changing their intention with respect to any and all matters referred to in Item 4 of Schedule 13D. Furthermore, the Reporting Person may seek to influence the Issuer to engage in share buy-backs, tenders, and liquidations and/or to change its governance, investment strategy and/or investment manager (which may be the Reporting Person). The Reporting Persons may, at any time and from time to time, review or reconsider their position and/or change their purpose and/or formulate plans or additional proposals with respect to their investment in the Common Shares. The Reporting Persons have not entered into any agreement with any third party to act together for the purpose of acquiring, holding, voting or disposing of the Common Shares reported herein.

  • Lulu's Fashion Lounge Holdings, Inc. 로고
    LVLULulu's Fashion Lounge Holdings, Inc.

    Friedland Enterprises LLC

    정정2026년 11월 20일 신고·사유 발생 2026년 11월 19일
    4.7%
    지분
    신고서에 적힌 목적(원문)

    EXPLANATORY NOTE This Amendment No. 2 amends and supplements the Schedule 13D originally filed by Christian B. Friedland ("Friedland" or the "Reporting Person"), through Friedland Enterprises, with the Securities and Exchange Commission on January 9, 2026, as amended by Amendment No. 1 filed on April 6, 2026 (as amended, the "Schedule 13D"), relating to the common stock, par value $0.001 per share (the "Shares"), of Lulu's Fashion Lounge Holdings, Inc. (the "Company"). Except as specifically set forth herein, the Schedule 13D is unmodified. This Amendment No. 2 is being filed to report that the Reporting Person has entered into a confidentiality agreement with the Company and that the Reporting Person beneficially owns less than five percent of the outstanding Shares. The decrease in the Reporting Person's percentage ownership results from an increase in the number of Shares outstanding and not from any disposition of Shares by the Reporting Person. This Amendment No. 2 is the final amendment to the Schedule 13D and constitutes an exit filing for the Reporting Person. Item 4 of the Schedule 13D is amended and supplemented by adding the following: On November 19, 2026, Friedland Enterprises, LLC entered into a confidentiality agreement with the Issuer. The Reporting Persons have paused public commentary regarding the Issuer.

  • Dine Brands Global, Inc. 로고
    DINDine Brands Global, Inc.

    Arkhouse Management Co. LP

    정정2026년 11월 20일 신고·사유 발생 2026년 11월 18일
    3.7%
    지분
    신고서에 적힌 목적(원문)

    Item 4 of the Schedule 13D is hereby amended and supplemented by the addition of the following: "On November 13, 2026, the Reporting Persons sent a letter to the Issuer (the "November 13 Letter"), requesting that the Issuer confirm that the Stockholder Rights Agreement, dated as of October 28, 2026, between the Issuer and Computershare Trust Company, N.A., as Rights Agent (the "Rights Agreement") would not be triggered if the Reporting Persons rebalanced their position to reduce their holdings of Total Return Swaps and increase their holdings of Common Stock; provided that their overall economic position, as measured by total shares of Common Stock and taken together with the overall economic position of Cobblers Cove, did not increase. On November 19, 2026, the Issuer sent a response letter stating its view that the proposed replacement transaction would trigger the Rights Agreement and cause the Rights (as defined in the Rights Agreement) to become exercisable, and declining to grant a waiver in connection therewith. The above summaries are qualified in their entirety by reference to the actual text of the November 13 Letter and the November 20 Response Letter, copies of which are filed herewith as Exhibit 99.7and Exhibit 99.8, respectively, and incorporated herein by reference. Item 5(c) of this Amendment is incorporated herein by reference."

  • Yarrow Bioscience, Inc. 로고
    YARWYarrow Bioscience, Inc.

    AI Biotechnology LLC

    정정2026년 11월 20일 신고·사유 발생 2026년 11월 13일
    1.16%
    지분

    이 신고서에는 목적을 적은 항목이 없어요.

  • Dine Brands Global, Inc. 로고
    DINDine Brands Global, Inc.

    Cobblers Cove Capital LP

    정정2026년 11월 20일 신고·사유 발생 2026년 11월 18일
    1.1%
    지분
    신고서에 적힌 목적(원문)

    Item 4 is hereby amended and supplemented by the addition of the following: "On November 13, 2026, Arkhouse Management Co. LP ("Arkhouse") sent a letter to the Issuer (the "November 13 Letter"), requesting that the Issuer confirm that the Stockholder Rights Agreement, dated as of October 28, 2026, between the Issuer and Computershare Trust Company, N.A., as Rights Agent (the "Rights Agreement") would not be triggered if Arkhouse rebalanced their position to reduce their holdings of Total Return Swaps and increase their holdings of Common Stock; provided that their overall economic position, as measured by total shares of Common Stock and taken together with the overall economic position of Cobblers Cove, did not increase. On November 19, 2026, the Issuer sent a response letter stating its view that the proposed replacement transaction would trigger the Rights Agreement and cause the Rights (as defined in the Rights Agreement) to become exercisable, and declining to grant a waiver in connection therewith. The above summaries are qualified in their entirety by reference to the actual text of the November 13 Letter and the November 20 Response Letter, copies of which are filed herewith as Exhibit 99.6 and Exhibit 99.7, respectively, and incorporated herein by reference. Item 5(c) of this Amendment is incorporated herein by reference."

  • KNOT Offshore Partners LP 로고
    KNOPKNOT Offshore Partners LP

    Astaris Capital Management LLP

    정정2026년 11월 20일 신고·사유 발생 2026년 11월 20일
    0%
    지분
    신고서에 적힌 목적(원문)

    This Schedule 13D Amendment No. 6 is being filed in connection with the matters discussed below. On November 20, 2026 (the "Closing Date"), the Reporting Persons and Knutsen NYK Offshore Tankers AS, a Norway limited company ("KNOT"), entered into a Unit Purchase Agreement (the "2026 Unit Purchase Agreement"), pursuant to which the Reporting Persons agreed to sell, and KNOT agreed to purchase, an aggregate of 2,789,070 Common Units from the Reporting Persons at a price of $12.5 per share (the "2026 Share Purchase"). The 2026 Unit Purchase Agreement contains customary representations, warranties and covenants of the parties. The 2026 Share Purchase contemplated by the 2026 Unit Purchase Agreement was consummated on November 20, 2026. Following the closing of the 2026 Share Purchase, the Reporting Persons ceased to beneficially own any Common Units of the Issuer. The 2026 Unit Purchase Agreement also contains customary non-disparagement and standstill provisions that, for a period of 24 months following the Closing Date and subject to certain exceptions, restrict the Reporting Persons from acquiring additional Common Units, joining or knowingly encouraging the formation of a "group" (within the meaning of Section 13(d)(3) of the Exchange Act) with respect to securities of the Issuer, instituting, soliciting, or joining any litigation against or involving the Issuer or KNOT, or taking certain actions with respect to the governance, management, or control of the Issuer, including engaging in certain proxy solicitations, making director nominations, or submitting proposals relating to extraordinary transactions. The foregoing description of the 2026 Unit Purchase Agreement does not purport to be complete and is qualified in its entirety by reference to the 2026 Unit Purchase Agreement, which is filed as Exhibit C hereto and incorporated herein by reference.

  • SoundThinking, Inc. 로고
    SSTISoundThinking, Inc.

    Transom Capital Public Fund, LP

    정정2026년 11월 20일 신고·사유 발생 2026년 11월 18일
    0%
    지분
    신고서에 적힌 목적(원문)

    Item 4 of the Schedule 13D is hereby amended and supplemented to include the following at the end thereof: As previously disclosed, on October 20, 2026, Merger Sub commenced the Offer to purchase any and all of the shares of Common Stock, other than certain exceptions, for (i) $8.00 per share of Common Stock, plus (ii) one non-transferable contingent value right per share of Common Stock (each, a "CVR"), which represents a right to receive up to $3.00, upon the achievement of specified milestones. The Reporting Persons tendered their 153,423 shares of Common Stock into the Offer. On November 18, 2026 (the "Closing Date"), Merger Sub accepted for payment all shares validly tendered and not validly withdrawn, including the 153,423 shares tendered by the Reporting Persons. In exchange, the Reporting Persons became entitled to receive aggregate cash consideration of $1,227,384 and 153,423 CVRs.

  • SoundThinking, Inc. 로고
    SSTISoundThinking, Inc.

    Gary M. Lauder

    정정2026년 11월 20일 신고·사유 발생 2026년 11월 18일
    0%
    지분
    신고서에 적힌 목적(원문)

    Item 4 is hereby amended and supplemented as follows: As previously disclosed, on October 20, 2026, Merger Sub commenced the Offer to purchase all outstanding shares of Common Stock for $8.00 per share in cash, without interest and subject to applicable withholding, plus one non-transferable contingent value right per share (each, a "CVR") representing the right to receive up to $3.00 in cash upon achievement of specified revenue milestones under the Contingent Value Rights Agreement among Parent, the Issuer and the rights agent (the "CVR Agreement"). The Offer expired at one minute after 11:59 p.m., New York City time, on November 17, 2026. Pursuant to the Support Agreement, each Reporting Person tendered all of the shares of Common Stock beneficially owned by it into the Offer and did not withdraw them. On November 18, 2026, Merger Sub accepted for payment all shares validly tendered and not validly withdrawn, including the 2,255,406 shares tendered by the Reporting Persons, consisting of 8,152 shares held directly by Mr. Lauder, 1,019,529 shares held by the Revocable Trust, 1,136,725 shares held by Lauder Partners and 91,000 shares held by the 2015 Trust. In exchange, the Reporting Persons became entitled to receive aggregate cash consideration of $18,043,248 (2,255,406 shares at $8.00 per share), before withholding, and 2,255,406 CVRs. On the same date, Merger Sub merged with and into the Issuer pursuant to Section 251(h) of the Delaware General Corporation Law, with the Issuer surviving as a wholly owned subsidiary of Parent. The Issuer has announced that the Common Stock will be delisted from Nasdaq and deregistered under the Exchange Act. The Reinvestment contemplated by the Support Agreement has not been completed as of the date of this Amendment. The Reinvestment Amount and the definitive limited partnership agreement of Topco remain under negotiation, and the Reinvestment remains subject to the applicable terms and conditions of the Support Agreement. Any equity interests acquired by the Reporting Persons in Holdco or Topco pursuant to the Reinvestment will not be shares of Common Stock of the Issuer. As a result of the foregoing, the Reporting Persons no longer beneficially own any shares of Common Stock and have ceased to be subject to the reporting requirements of Section 13(d) of the Exchange Act with respect to the Common Stock. Except as described herein, the Reporting Persons have no further plans or proposals with respect to the matters specified in Item 4(a) through (j) of Schedule 13D.

  • UWM Holdings Corporation 로고
    UWMCUWM Holdings Corporation

    Mat Ishbia

    정정2026년 11월 19일 신고·사유 발생 2026년 11월 17일
    80.2%
    지분
    신고서에 적힌 목적(원문)

    Item 4 of the Schedule 13D is hereby amended by the addition of the following: The information contained above in Item 3 of this Amendment is incorporated herein by reference. On September 1, 2026, SFS Corp. approved by written consent in lieu of a special meeting, in accordance with Section 228 of the Delaware General Corporation Law and Section 8 of the Issuer's Certificate of Incorporation, the issuance of shares of Class A Stock upon the exercise of the Warrants issued to SFS Capital and the issuance of Class A Stock if issued pursuant to the Backstop Agreement. Such approval was required by the rules of the New York Stock Exchange. The Issuer disseminated an Information Statement on Schedule 14C notifying the Issuer's stockholders of such consent and such actions became effective on October 24, 2026. Consequently, all Warrants are now fully exercisable.

  • Vertical Aerospace Ltd. 로고
    EVTWFVertical Aerospace Ltd.

    Mudrick Capital Management, L.P.

    정정2026년 11월 19일 신고·사유 발생 2026년 11월 17일
    64.2%
    지분
    신고서에 적힌 목적(원문)

    This Item 4 of the Schedule 13D is amended and supplemented as follows: On November 17, 2026, the Board appointed Jason Mudrick to serve as a director. Mr. Mudrick had been nominated to serve as a director of the Company pursuant to the Company's Sixth Amended and Restated Memorandum and Articles of Association (the "Articles") by Mudrick Capital Management, L.P., on behalf of certain funds, investors, entities or accounts that are managed, sponsored or advised by it or its affiliates ("MCM"). The Company issued a press release announcing Mr. Mudrick's appointment, which is attached as Exhibit 99.1 hereto and is incorporated herein by reference. The Board also previously appointed Fabrice Bregier, Marc Fontaine, Andy Teich and Clyde Woltman to serve as directors following their nomination by MCM pursuant to the Articles.

  • Stablecoin Development Corp 로고
    SDEVStablecoin Development Corp

    R01 Fund LP

    정정2026년 11월 19일 신고·사유 발생 2026년 11월 17일
    30.7%
    지분
    신고서에 적힌 목적(원문)

    The Reporting Person has exercised its right under the IRA to nominate one director to the Issuer's board of directors. On November 10, 2026, the Reporting Person's nominee, Russell Preston Cann, was elected as a Class I director of the Issuer at the Issuer's 2026 Annual Meeting of Stockholders, with a term expiring at the Issuer's 2029 Annual Meeting of Stockholders.

  • Stablecoin Development Corp 로고
    SDEVStablecoin Development Corp

    Framework Ventures IV L.P.

    정정2026년 11월 19일 신고·사유 발생 2026년 11월 17일
    30.7%
    지분

    이 신고서에는 목적을 적은 항목이 없어요.

  • dLocal Ltd 로고
    DLOdLocal Ltd

    GENERAL ATLANTIC, L.P.

    정정2026년 11월 19일 신고·사유 발생 2026년 11월 17일
    13.4%
    지분
    신고서에 적힌 목적(원문)

    No material change.

  • RILEY EXPLORATION PERMIAN, INC. 로고
    REPXRILEY EXPLORATION PERMIAN, INC.

    The Estate of Alvin Libin

    2026년 11월 19일 신고·사유 발생 2026년 11월 12일
    10.11%
    지분
    신고서에 적힌 목적(원문)

    The Reporting Persons are filing this statement on Schedule 13D to report its acquisition, through operation of law, of beneficial ownership of more than 5% of the outstanding Common Shares of the Issuer, following the passing of Alvin G. Libin and the appointment of the Trustees as the trustees of the Estate. Other than as described in this Item 4, or otherwise in this Statement, each of the Reporting Persons and the Trustees (individually and in their capacity as a trustee of the Estate) currently has no plans or proposals which relate to or would result in any of the matters set forth in subparagraphs (a)-(j) of Item 4 of Form Schedule 13D. In the foregoing capacities, each Trustee reserves the right, in light of their future evaluation of the Issuer's financial condition, business, operations and prospects, the market price of the Common Shares, conditions in the securities markets generally, general economic and industry conditions and other relevant factors, to change their plans and intentions at any time, as they deem appropriate.

  • Solana Co 로고
    HSDTSolana Co

    Daniel W. Morehead

    정정2026년 11월 19일 신고·사유 발생 2026년 11월 17일
    9.54%
    지분
    신고서에 적힌 목적(원문)

    Item 4 of the Statement is hereby amended and supplemented as follows: The information set forth or incorporated in Item 3 and Item 6 of this Amendment is hereby incorporated by reference in its entirety into this Item 4. On November 17, 2026, DAT Opportunities Fund transferred 581,311 shares of Common Stock to Blockchain Fund for cash at $1.635 per share, the closing price on November 17, 2026. Other than as described in this Item 4, none of the Reporting Persons presently has any additional plans or proposals that relate to or that would result in any of the transactions or other matters specified in clauses (a) through (j) of Item 4 of this Schedule 13D, but depending on the factors discussed herein, the Reporting Persons may change their purpose or formulate different plans or proposals with respect to their investment in the Issuer at any time.

  • Brookdale Senior Living Inc. 로고
    BKDBrookdale Senior Living Inc.

    CARRONADE CAPITAL MANAGEMENT, LP

    2026년 11월 19일 신고·사유 발생 2026년 11월 13일
    5.8%
    지분
    신고서에 적힌 목적(원문)

    The Reporting Persons acquired the shares of Common Stock reported herein for investment purposes because they believe the shares are undervalued and represent an attractive investment opportunity. In particular, the Reporting Persons believe there is a significant gap between the valuation implied by the current market price of the Common Stock and the intrinsic value of the Issuer's business and assets, relative to both public comparables and private market values. The Reporting Persons have had, and expect to continue, discussions with the Issuer's Board of Directors (the "Board") and management regarding strategic opportunities to maximize shareholder value, including the Issuer's ability to realize the full value of its business and assets. The topics of these discussions have covered, and may in the future cover, a range of matters, including capital allocation, investor communications, management, board composition, portfolio optimization, mergers and acquisitions strategy, REIT conversion, a review of some or all of the Issuer's assets, and other opportunities to maximize shareholder value. The Reporting Persons may also have similar conversations with other stockholders or other interested parties, such as industry analysts, existing or potential strategic partners, competitors, investment professionals, and other investors, and may exchange information with any such persons or the Issuer pursuant to appropriate confidentiality or similar agreements. The Reporting Persons intend to review their investment in the Issuer on a continuing basis and depending upon various factors, including, without limitation, the Issuer's financial position and strategic direction, the outcome of any discussions or matters referenced above, overall market conditions, other investment opportunities available to the Reporting Persons, and the availability of securities of the Issuer at prices that would make the purchase or sale of such securities desirable, the Reporting Persons may endeavor (i) to increase or decrease their position in the Issuer through, among other things, the purchase or sale of securities of the Issuer, including through transactions involving the Common Stock and/or other equity, debt, notes, other securities, or derivative or other instruments that are based upon or relate to the value of securities of the Issuer in the open market or in private transactions, including through a trading plan created under Rule 10b5-1(c) or otherwise, on such terms and at such times as the Reporting Persons may deem advisable and/or (ii) to enter into transactions that increase or hedge their economic exposure to the Common Stock without affecting their beneficial ownership of the Common Stock. In addition, the Reporting Persons may, at any time and from time to time, (i) review or reconsider their position and/or change their purpose and/or formulate plans or proposals with respect thereto and (ii) consider or propose one or more of the actions described in subparagraphs (a) - (j) of Item 4 of Schedule 13D.

  • PRF Technologies Ltd. 로고
    PRFXPRF Technologies Ltd.

    S.H.N. Financial Investments Ltd.

    정정2026년 11월 19일 신고·사유 발생 2026년 11월 18일
    5.716%
    지분
    신고서에 적힌 목적(원문)

    Item 4 of the Schedule 13D is hereby amended to add the following at the end thereof: On November 13, 2026, the Issuer published a notice convening its annual general meeting of shareholders for December 21, 2026 (the "Annual Meeting"). The notice refers to the pending Petition, but the agenda excludes the matters that are the subject of the Petition. It does include the re-election of Mr. Asaf Shavit, one of the directors whose replacement S.H.N. seeks, as a Class II director. By letter dated November 15, 2026 (the "Agenda Demand"), S.H.N. demanded, pursuant to Section 66(b) of the Israeli Companies Law, 5759-1999 (the "Companies Law") and Article 20(b)(3) of the Issuer's Articles of Association, that the agenda of the Annual Meeting include resolutions (the "Proposed Resolutions"): (i) to remove from office, immediately upon the closing of the Annual Meeting, each of the following currently serving directors: Dr. Ehud Geller, Mr. Efi Cohen-Arazi and Mr. Asaf Shavit; (ii) to elect Ms. Margarita Hirsch Malahovich as a Class I director of the Issuer, for the remainder of the applicable term of such class and until her successor is duly elected and qualified; (iii) to elect Ms. Liat Katzman as a Class II director of the Issuer, as an alternative to the re-election of Mr. Asaf Shavit, for the new term of such class and until her successor is duly elected and qualified; and (iv) to elect Mr. Amos Pickel as a Class III director of the Issuer, for the remainder of the applicable term of such class and until his successor is duly elected and qualified. S.H.N. further demanded that the Issuer publish an amended notice of the Annual Meeting, together with updated proxy materials, that include the Proposed Resolutions, and that it confirm in writing by 9:00 a.m. (Israel time) on November 17, 2026, that it would do so. S.H.N. also stated that, absent such confirmation, it would apply to the Court to amend the Petition. A copy of the Agenda Demand is attached hereto as Exhibit 2. The Issuer did not provide such confirmation, and as of the date hereof has not amended the notice of the Annual Meeting or included the Proposed Resolutions on its agenda. Accordingly, on November 18, 2026, S.H.N. filed the Motion with the Court. The Motion seeks leave to amend the Petition so that the Court, exercising its general authority under Section 72 of the Companies Law, would direct the Issuer to add the Proposed Resolutions to the agenda of the Annual Meeting and put them to a shareholder vote. The Motion further asks that the Issuer publish, without delay, an amended notice and updated proxy materials that include the Proposed Resolutions. This relief is in addition to the other relief set forth in the amended Petition. The Motion also asks the Court to keep November 24, 2026, as the Issuer's deadline to respond to the amended Petition.

출처: SEC EDGAR. 2024년 12월 18일부터 항목별로 정리된 신고서만 다뤄요. 공시 원문에 적힌 사실만 옮겼어요. 참고용이며 매수·매도 권유가 아니에요.